Critical Illness Neuromuscular Syndromes

Neurologic Clinics

Volumn 26, Issue 2, 2008, Pages 507-520

  De Jonghe, Bernard ^a   Lacherade, Jean Claude ^a   Durand, Marie Christine ^b   Sharshar, Tarek ^b  

^a CENTRE HOSPITALIER INTERCOMMUNAL   (France)

^b RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ALBUMIN; CARBON MONOXIDE; CHOLINERGIC RECEPTOR; CORTICOSTEROID; CREATINE KINASE; GLUCOSE; INSULIN; SUXAMETHONIUM; UBIQUITIN;

ALBUMIN BLOOD LEVEL; ARTIFICIAL VENTILATION; ASTHMA; BLOOD GLUCOSE MONITORING; BREATHING MUSCLE; CARBON MONOXIDE BLOOD LEVEL; CARDIOPULMONARY INSUFFICIENCY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EXAMINATION; CONFIDENCE INTERVAL; CREATINE KINASE BLOOD LEVEL; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DISEASE SEVERITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTROMYOGRAM; ENDOTRACHEAL INTUBATION; GLUCOSE BLOOD LEVEL; GUILLAIN BARRE SYNDROME; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; HYPERKALEMIA; HYPEROSMOLALITY; INCIDENCE; INSULIN TREATMENT; INTENSIVE CARE UNIT; LIMB WEAKNESS; MORTALITY; MULTIPLE ORGAN FAILURE; MUSCLE BIOPSY; MUSCLE FUNCTION; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; NEUROMUSCULAR DISEASE; NEUROMUSCULAR SYNAPSE; NONHUMAN; PARENTERAL NUTRITION; PATHOPHYSIOLOGY; PATIENT CARE; PERFORMANCE MEASUREMENT SYSTEM; PERIPHERAL NERVE; PHYSICAL PERFORMANCE; PREVALENCE; PRIORITY JOURNAL; PULSE OXIMETER; RENAL REPLACEMENT THERAPY; REVIEW; RISK; SEPSIS; UPREGULATION;

ACUTE DISEASE; CRITICAL CARE; CRITICAL ILLNESS; HUMANS; NEUROMUSCULAR DISEASES; RISK FACTORS;

EID: 44349142885     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2008.03.001     Document Type: Review

References (73)

1. Bolton C.F., Gilbert J.J., Fhahn A., et al. Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatr 47 (1984) 1223-1231
2. Kleyweg R.P., van der Meche F.G., and Meulstee J. Treatment of Guillain-Barre syndrome with high-dose gammaglobulin. Neurology 38 (1988) 1639-1641
3. Kleyweg R.P., VanDerMeché F.G., and Schmitz P.I. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve 14 (1991) 1103-1109
4. Gregson J.M., Leathley M.J., Moore A.P., et al. Reliability of measurements of muscle tone and muscle power in stroke patients. Age Ageing 29 (2000) 223-228
5. De Jonghe B., Sharshar T., Lefaucheur J.P., et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 288 (2002) 2859-2867
6. Leijten F.S., Harinck-de-Weerd J.E., Poortvliet D.C., et al. The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. JAMA 275 (1995) 442-443
7. van der Schaaf M., Beelen A., and de Groot I.J. Critical illness polyneuropathy: a summary of the literature on rehabilitation outcome. Disabil Rehabil 22 (2000) 808-810
8. Herridge M.S., Cheung A.M., Tansey C.M., et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 348 (2003) 683-693
9. Latronico N., Shehu I., and Seghelini E. Neuromuscular sequelae of critical illness. Curr Opin Crit Care 11 (2005) 381-390
10. De Jonghe B., Cook D., Sharshar T., et al. Acquired neuromuscular disorders in critically ill patients: a systematic review. Intensive Care Med 24 (1998) 1242-1250
11. Khan J., Harrison T.B., Rich M.M., et al. Early development of critical illness myopathy and neuropathy in patients with severe sepsis. Neurology 67 (2006) 1421-1425
12. Rich M.M., Bird S.J., Raps E.C., et al. Direct muscle stimulation in acute quadriplegic myopathy. Muscle Nerve 20 (1997) 665-673
13. Bednarik J., Lukas Z., and Vondracek P. Critical illness polyneuromyopathy: the electrophysiological components of a complex entity. Intensive Care Med 29 (2003) 1505-1514
14. Lefaucheur J.P., Nordine T., Rodriguez P., et al. Origin of ICU acquired paresis determined by direct muscle stimulation. J Neurol Neurosurg Psychiatry 77 (2006) 500-506
15. Douglass J. Myopathy in severe asthma. Am Rev Respir Dis 146 (1992) 517-519
16. Leijten F., de-Weerd A., Poortvliet D., et al. Critical illness polyneuropathy in multiple organ dysfunction syndrome and weaning from the ventilator. Intensive Care Med 22 (1996) 856-861
17. Thiele R.I., Jakob H., Hund E., et al. Critical illness polyneuropathy: a new iatrogenically induced syndrome after cardiac surgery?. Eur J Cardiothorac Surg 12 (1997) 826-835
18. Thiele R.I., Jakob H., Hund E., et al. Sepsis and catecholamine support are the major risk factors for critical illness polyneuropathy after open heart surgery'. [In Process Citation]. Thorac Cardiovasc Surg 48 (2000) 145-150
19. Garnacho-Montero J., Madrazo-Osuna J., Garcia-Garmendia J.L., et al. Critical illness polyneuropathy: risk factors and clinical consequences: a cohort study in septic patients. Intensive Care Med 27 (2001) 1288-1296
20. Druschky A., Herkert M., Radespiel-Troger M., et al. Critical illness polyneuropathy: clinical findings and cell culture assay of neurotoxicity assessed by a prospective study. Intensive Care Med 27 (2001) 686-693
21. Garnacho-Montero J., Amaya-Villar R., Garcia-Garmendia J.L., et al. Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay in septic patients. Crit Care Med 33 (2005) 349-354
22. Amaya-Villar R., Garnacho-Montero J., Garcia-Garmendia J.L., et al. Steroid-induced myopathy in patients intubated due to exacerbation of chronic obstructive pulmonary disease. Intensive Care Med 31 (2005) 157-161
23. De Jonghe B., Bastuji-Garin S., Sharshar T., et al. Does ICU-acquired paresis lengthen weaning from mechanical ventilation?. Intensive Care Med 30 (2004) 1117-1121
24. Maher J., Rutledge F., Remtulla H., et al. Neuromuscular disorders associated with failure to wean from the ventilator. Intensive Care Med 21 (1995) 737-743
25. Zifko U.A., Zipko H.T., and Bolton C.F. Clinical and electrophysiological findings in critical illness polyneuropathy. J Neurol Sci 159 (1998) 186-193
26. Meade M., Guyatt G., Cook D., et al. Predicting success in weaning from mechanical ventilation. Chest 120 (2001) S400-S424
27. De Jonghe B., Bastuji-Garin S., Durand M.C., et al. Respiratory weakness is associated with limb weakness and delayed weaning in critical illness. Crit Care Med 35 (2007) 2007-2015
28. Hussain S.N. Respiratory muscle dysfunction in sepsis. Mol Cell Biochem 179 (1998) 125-134
29. Laghi F., and Tobin M.J. Disorders of the respiratory muscles. Am J Respir Crit Care Med 168 (2003) 10-48
30. Le Bourdelles G., Viires N., Boczkowski J., et al. Effects of mechanical ventilation on diaphragmatic contractile properties in rats. Am J Respir Crit Care Med 149 (1994) 1539-1544
31. Powers S.K., Shanely R.A., Coombes J.S., et al. Mechanical ventilation results in progressive contractile dysfunction in the diaphragm. J Appl Physiol 92 (2002) 1851-1858
32. Sassoon C.S., Zhu E., and Caiozzo V.J. Assist-control mechanical ventilation attenuates ventilator-induced diaphragmatic dysfunction. Am J Respir Crit Care Med 170 (2004) 626-632 Epub 2004 Jun 2016
33. Witt N.J., Zochodne D.W., Bolton C.F., et al. Peripheral nerve function in sepsis and multiple organ failure. Chest 99 (1991) 176-184
34. Campellone J.V., Lacomis D., Kramer D.J., et al. Acute myopathy after liver transplantation. Neurology 50 (1998) 46-53
35. de Letter M.A., Schmitz P.I., Visser L.H., et al. Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med 29 (2001) 2281-2286
36. Bednarik J., Vondracek P., Dusek L., et al. Risk factors for critical illness polyneuromyopathy. J Neurol 252 (2005) 343-351
37. Van den Berghe G., Schoonheydt K., Becx P., et al. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 64 (2005) 1348-1353
38. Hermans G., Wilmer A., Meersseman W., et al. Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med 175 (2007) 480-489
39. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 345 (2001) 1359-1367
40. Van den Berghe G., Wilmer A., Hermans G., et al. Intensive insulin therapy in the medical ICU. N Engl J Med 354 (2006) 449-461
41. Annane D., Sebille V., Charpentier C., et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288 (2002) 862-871
42. Annane D., Bellissant E., Bollaert P.E., et al. Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. BMJ 329 (2004) 480-488
43. Steinberg K.P., Hudson L.D., Goodman R.B., et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 354 (2006) 1671-1684
44. Segredo V., Caldwell J., Matthay M., et al. Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med 327 (1992) 524-528
45. Leatherman J., Fluegel W., David W., et al. Muscle weakness in mechanically ventilated patients with severe asthma. Am J Respir Crit Care Med 153 (1996) 1686-1690
46. Adnet F., Dhissi G., Borron S.W., et al. Complication profiles of adult asthmatics requiring paralysis during mechanical ventilation. Intensive Care Med 27 (2001) 1729-1736
47. Behbehani N.A., Al-Mane F., D'Yachkova Y., et al. Myopathy following mechanical ventilation for acute severe asthma: the role of muscle relaxants and corticosteroids. Chest 115 (1999) 1627-1631
48. Latronico N., Fenzi F., Recupero D., et al. Critical illness myopathy and neuropathy. Lancet 347 (1996) 1579-1582
49. Hasselgren P.O., and Fischer J.E. Muscle cachexia: current concepts of intracellular mechanisms and molecular regulation. Ann Surg 233 (2001) 9-17
50. Chai J., Wu Y., and Sheng Z.Z. Role of ubiquitin-proteasome pathway in skeletal muscle wasting in rats with endotoxemia. Crit Care Med 31 (2003) 1802-1807
51. Rabuel C., Renaud E., Brealey D., et al. Human septic myopathy: induction of cyclooxygenase, heme oxygenase and activation of the ubiquitin proteolytic pathway. Anesthesiology 101 (2004) 583-590
52. Tiao G., Fagan J., Roegner V., et al. Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids. J Clin Invest 97 (1996) 339-348
53. Brealey D., Brand M., Hargreaves I., et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360 (2002) 219-223
54. Rouleau G., Karpati G., Carpenter S., et al. Glucocorticoid excess induces preferential depletion of myosin in denervated skeletal muscle fibers. Muscle Nerve 10 (1987) 428-438
55. Massa R., Carpenter S., Holland P., et al. Loss and renewal of thick myofilaments in glucocorticoid-treated rat soleus after denervation and reinnervation. Muscle Nerve 15 (1992) 1290-1298
56. Hickson R.C., Wegrzyn L.E., Osborne D.F., et al. Alanyl-glutamine prevents muscle atrophy and glutamine synthetase induction by glucocorticoids. Am J Physiol 271 (1996) R1165-R1172
57. McKay L.I., Du Bois D.C., Sun Y.N., et al. Corticosteroid effects in skeletal muscle: gene induction/receptor autoregulation. Muscle Nerve 20 (1997) 1318-1320
58. Rich M.M., Pinter M.J., Kraner S.D., et al. Loss of electrical excitability in an animal model of acute quadriplegic myopathy. Ann Neurol 43 (1998) 171-179
59. Rich M.M., and Pinter M.J. Crucial role of sodium channel fast inactivation in muscle fibre inexcitability in a rat model of critical illness myopathy. J Physiol 547 (2003) 555-566
60. Vanhorebeek I., De Vos R., Mesotten D., et al. Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 365 (2005) 53-59
61. Verheul G.A., de Jongh-Leuvenink J., Op de Coul A.A., et al. Tumor necrosis factor and interleukin-6 in critical illness polyneuromyopathy. Clin Neurol Neurosurg 96 (1994) 300-304
62. Bolton C. Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med 24 (1996) 1408-1416
63. Fenzi F., Latronico N., Refatti N., et al. Enhanced expression of E-selectin on the vascular endothelium of peripheral nerve in critically ill patients with neuromuscular disorders. Acta Neuropathol (Berl) 106 (2003) 75-82
64. Griffiths R.D., Palmer T.E., Helliwell T., et al. Effect of passive stretching on the wasting of muscle in the critically ill. Nutrition 11 (1995) 428-432
65. Brook A.D., Ahrens T.S., Schaiff R., et al. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med 27 (1999) 2609-2615
66. Kress J., Pohlman A., O'Connor M., et al. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 342 (2000) 1471-1477
67. De Jonghe B., Bastuji-Garin S., Fangio P., et al. Sedation algorithm in critically ill patients without acute brain injury. Crit Care Med 33 (2005) 120-127
68. Mohr M., Englisch L., Roth A., et al. Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram-negative sepsis. Intensive Care Med 23 (1997) 1144-1149
69. Horton W.A., and Fergusson N.V. Hyperkalaemia and cardiac arrest after the use of suxamethonium in intensive care. Anaesthesia 43 (1988) 890-891
70. Hemming A.E., Charlton S., and Kelly P. Hyperkalaemia, cardiac arrest, suxamethonium and intensive care. Anaesthesia 45 (1990) 990-991
71. Dornan R.I., and Royston D. Suxamethonium-related hyperkalaemic cardiac arrest in intensive care. Anaesthesia 50 (1995) 1006
72. Markewitz B.A., and Elstad M.R. Succinylcholine-induced hyperkalemia following prolonged pharmacologic neuromuscular blockade. Chest 111 (1997) 248-250
73. Hughes M., Grant I.S., Biccard B., et al. Suxamethonium and critical illness polyneuropathy. Anaesth Intensive Care 27 (1999) 636-638